203 related articles for article (PubMed ID: 8670421)
1. Central hypotensive effects of the alpha2a-adrenergic receptor subtype.
MacMillan LB; Hein L; Smith MS; Piascik MT; Limbird LE
Science; 1996 Aug; 273(5276):801-3. PubMed ID: 8670421
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.
Link RE; Desai K; Hein L; Stevens ME; Chruscinski A; Bernstein D; Barsh GS; Kobilka BK
Science; 1996 Aug; 273(5276):803-5. PubMed ID: 8670422
[TBL] [Abstract][Full Text] [Related]
3. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.
Stone LS; MacMillan LB; Kitto KF; Limbird LE; Wilcox GL
J Neurosci; 1997 Sep; 17(18):7157-65. PubMed ID: 9278550
[TBL] [Abstract][Full Text] [Related]
4. Moxonidine, a selective alpha2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice.
Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 1999 Jul; 290(1):403-12. PubMed ID: 10381806
[TBL] [Abstract][Full Text] [Related]
5. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
Wang X; Li G; Abdel-Rahman AA
Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
[TBL] [Abstract][Full Text] [Related]
6. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
Mukaddam-Daher S; Menaouar A; Gutkowska J
Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
[TBL] [Abstract][Full Text] [Related]
7. ST91 [2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride]-mediated spinal antinociception and synergy with opioids persists in the absence of functional alpha-2A- or alpha-2C-adrenergic receptors.
Stone LS; Kitto KF; Eisenach JC; Fairbanks CA; Wilcox GL
J Pharmacol Exp Ther; 2007 Dec; 323(3):899-906. PubMed ID: 17855473
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference.
Burke J; Kharlamb A; Shan T; Runde E; Padillo E; Manlapaz C; Wheeler L
Ann N Y Acad Sci; 1995 Jul; 763():78-95. PubMed ID: 7677389
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide discriminates the sites and mechanisms of action of centrally acting anti-hypertensive drugs in rabbits.
Sy GY; Bruban V; Bousquet P; Feldman J
Neuropharmacology; 2002 Dec; 43(8):1330-8. PubMed ID: 12527483
[TBL] [Abstract][Full Text] [Related]
10. Participation of imidazoline receptors and alpha(2-)-adrenoceptors in the central hypotensive effects of imidazoline-like drugs.
Bousquet P; Bruban V; Schann S; Greney H; Ehrhardt JD; Dontenwill M; Feldman J
Ann N Y Acad Sci; 1999 Jun; 881():272-8. PubMed ID: 10415925
[TBL] [Abstract][Full Text] [Related]
11. Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo.
Lakhlani PP; MacMillan LB; Guo TZ; McCool BA; Lovinger DM; Maze M; Limbird LE
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9950-5. PubMed ID: 9275232
[TBL] [Abstract][Full Text] [Related]
12. alpha(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice.
Tolentino-Silva FP; Haxhiu MA; Waldbaum S; Dreshaj IA; Ernsberger P
Brain Res; 2000 Apr; 862(1-2):26-35. PubMed ID: 10799665
[TBL] [Abstract][Full Text] [Related]
13. Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulation.
Bruban V; Estato V; Schann S; Ehrhardt JD; Monassier L; Renard P; Scalbert E; Feldman J; Bousquet P
Circulation; 2002 Mar; 105(9):1116-21. PubMed ID: 11877365
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat.
Buerkle H; Yaksh TL
Br J Anaesth; 1998 Aug; 81(2):208-15. PubMed ID: 9813525
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Cl- secretion by alpha2-adrenergic receptors in mouse colonic epithelium.
Lam RS; App EM; Nahirney D; Szkotak AJ; Vieira-Coelho MA; King M; Duszyk M
J Physiol; 2003 Apr; 548(Pt 2):475-84. PubMed ID: 12598592
[TBL] [Abstract][Full Text] [Related]
16. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype.
Sallinen J; Haapalinna A; Viitamaa T; Kobilka BK; Scheinin M
Neuroscience; 1998 Oct; 86(3):959-65. PubMed ID: 9692731
[TBL] [Abstract][Full Text] [Related]
17. Gene substitution/knockout to delineate the role of alpha 2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines.
Hein L; Limbird LE; Eglen RM; Kobilka BK
Ann N Y Acad Sci; 1999 Jun; 881():265-71. PubMed ID: 10415924
[TBL] [Abstract][Full Text] [Related]
18. Alpha2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus.
Peng N; Chambless BD; Oparil S; Wyss JM
Hypertension; 2003 Mar; 41(3):571-5. PubMed ID: 12623961
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
[TBL] [Abstract][Full Text] [Related]
20. Proteomic exploration of pancreatic islets in mice null for the alpha2A adrenergic receptor.
Hu X; Friedman D; Hill S; Caprioli R; Nicholson W; Powers AC; Hunter L; Limbird LE
J Mol Endocrinol; 2005 Aug; 35(1):73-88. PubMed ID: 16087723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
